Blueline Advisors’s iShares US Medical Devices ETF IHI Stock Holding History

Blueline Advisors’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.92K	Buy	+45	New	+$2.28K	﹤0.01%	227

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Blueline Advisors's IHI Position: Q2 2026 in Review

Blueline Advisors opened a new position in iShares US Medical Devices ETF (IHI) in Q2 2026: 45 shares worth $2.92K. The stake represents ﹤0.01% of the portfolio and ranks #227 among its holdings.

500 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

Blueline Advisors held 45 shares of iShares US Medical Devices ETF worth $2.92K as of Q2 2026.
iShares US Medical Devices ETF was a new Blueline Advisors position in Q2 2026.
iShares US Medical Devices ETF made up ﹤0.01% of Blueline Advisors's portfolio in Q2 2026, its #227 holding.
500 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Blueline Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.